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Abstract 
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Objective: We explored both within-method and between-method rigor and reproducibility in 
the field of eating disorders genetics. 
Method: We present critical evaluation and commentary on component methods of genetic 
research (family studies, twin studies, molecular genetic studies) and discuss both successful and 
unsuccessful efforts in the field. 
Results: Eating disorders genetics has had a number of robust results that converge across 
component methodologies. Familial aggregation of eating disorders, twin-based heritability 
estimates of eating disorders, and genome-wide association studies (GWAS) all point toward a 
substantial role for genetics in eating disorders etiology and support the premise that genes do 
not act alone. Candidate gene and linkage studies have been less informative historically. 
Discussion: The eating disorders field has entered the GWAS era with studies of anorexia 
nervosa. Continued growth of sample sizes is essential for rigorous discovery of actionable 
variation. Molecular genetic studies of bulimia nervosa, binge-eating disorder, and other eating 
disorders are virtually nonexistent and lag seriously behind other major psychiatric disorders. 
Expanded efforts are necessary to reveal the fundamental biology of eating disorders, inform 
clinical practice, and deliver new therapeutic targets. 
 
 
Keywords: anorexia nervosa, bulimia nervosa, binge-eating disorder, GWAS, polygenic risk 
score, genetic correlation, pathway 
 
1. Introduction 
The goal of genetic research in eating disorders is to decipher basic mechanisms that contribute 
to or modulate risk of developing these complex phenotypes. Eating disorders, like all 
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psychiatric illnesses, are complex traits that that are influenced by hundreds or even thousands of 
variants of small to moderate effect (i.e., polygenicity) together with environmental factors 
(Gelernter, 2015; Plomin, Haworth, & Davis, 2009).  
Genetic findings inform a wide array of functional investigations from genetically 
modified cells to animal models, and can potentially guide new drug development or repurposing 
of existing medications (Breen et al., 2016; Yilmaz, Hardaway, & Bulik, 2015). Health science 
research for eating disorders is underfunded relative to their contribution to global disability 
adjusted life-years (Insel, 2015; Murray, Pila, Griffiths, & Le Grange, 2017). Consequently, the 
use of resources must be optimized to guarantee the generation of reproducible and robust 
findings. Genetic research offers myriad opportunities to understand eating disorders on 
molecular, cellular, and systems biology levels and is envisioned to improve risk prediction, 
therapeutic interventions, and preventive strategies (Sullivan et al., 2018).  
DNA is the underlying blueprint of the organism and interindividual changes in this 
blueprint are partially responsible for the observed differences between individuals. Our genome 
is assigned at conception and remains essentially stable throughout life. This stability means that 
it is prone to far fewer confounding factors than are necessary to attend to in other fields, 
including epidemiology and epigenetics. Specifically, genetics is robust to reverse causation, 
and, with epidemiologically informed statistical analyses, allows for causal interpretation of 
findings. For genomics to be optimally informative, it is important to achieve the broadest 
possible coverage of the genome.  
There are tens of millions of common genetic variants (i.e., present in at least 1% of the 
population), of many different types, throughout the genome. The most common variants are 
single base pair changes, such as adenine (A) to thymine (T), which are referred to as single 
nucleotide polymorphisms or SNPs. Current technology based on DNA microarrays allows 
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direct measurement (“genotyping”) of SNPs at between 500,000 to 5 million positions. 
Thereafter, imputation methods are used in conjunction with reference panels from whole 
genome sequencing (1000 Genomes Project Consortium et al., 2012; International HapMap 
Consortium, 2005; McCarthy et al., 2016) to boost the information content in the data by 
allowing the prediction of genotypes at positions not measured on the arrays, thereby increasing 
coverage of the genome and improving power to detect associations.  
Eating disorders genetics to date has yielded many robust, rigorous, and reproducible 
results, both within and across component methodologies (see Table 1). In this review, we will 
focus on family, twin, and molecular genetic approaches highlighting convergent results and 
briefly review the history of candidate gene studies in eating disorders. First, we introduce the 
concept of heritability, which is central to understanding genetic studies of eating disorders. We 
recommend returning to this section after reading the entire paper to consolidate your 
understanding of the concept. Second, we briefly introduce the methodologies covered in this 
review: family, twin, linkage, candidate gene, genome-wide association studies (GWAS), their 
follow-on approaches, whole genome and exome sequencing, and epigenetics. Finally, we 
review four critical concepts necessary to evaluate the rigor of eating disorders genetics literature 
in an informed manner: phenotype, relatedness, population stratification, and sample size. Of 
note, comprehensive reviews of the findings of genetic studies in eating disorders are available, 
see Brandys et. al (2015), Breithaupt, Hübel, & Bulik (2018), Davis (2015), Hinney and 
Volckmar (2013), Yilmaz et al. (2015). 
 
2. Heritability (h2) 
In general, heritability (h2) refers to the proportion of phenotypic variance due to inherited (non-
environmental) factors (see Box 1). 
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Box 1: Narrow-sense vs. broad-sense heritability 
The reader should be mindful of the difference between h2 (narrow-sense heritability) which 
captures the proportion of variance attributed to variation in additive genetic values and H2 
(broad-sense heritability), which captures the proportion of variance attributed to variation in 
total genetic values (Visscher, Hill, & Wray, 2008). 
 
Numerically, h2 estimates range from 0 (i.e., no effect of genes on phenotypic variation) to 1.0 
(genes are the only contributor to phenotypic variation). The h2 estimates for eating disorders can 
be derived from family studies (Javaras et al., 2008; Strober, Lampert, Morrell, Burroughs, & 
Jacobs, 1990), twin studies (Baker, Mitchell, Neale, & Kendler, 2010; Bulik et al., 2006, 2010; 
Bulik, Sullivan, & Kendler, 1998; Dellava, Thornton, Lichtenstein, Pedersen, & Bulik, 2011; 
Javaras et al., 2008; Klump, Miller, Keel, McGue, & Iacono, 2001; Kortegaard, Hoerder, 
Joergensen, Gillberg, & Kyvik, 2001; Mazzeo et al., 2009, 2010; Mitchell et al., 2010; Trace et 
al., 2013; Wade, Bulik, Neale, & Kendler, 2000), adoption studies (Klump, Suisman, Burt, 
McGue, & Iacono, 2009), and genomic studies (Duncan et al., 2017). The extent to which h2 
estimates across various methods converge is one measure of reproducibility in eating disorder 
genetics. As described below, differences in h2 estimates across approaches should be expected 
and indeed are observed (reasons for this are covered in greater detail in section SNP-based h2; 
Table 1). Critical to recognize is that h2 is a population statistic (not an individual measure) and 
refers to a given population at a given point in time. The occurrence and frequencies of genetic 
variants can differ across populations for several reasons, including chance, migration, mutation, 
and selection (Wray & Visscher, 2008). Therefore, applying results from one population to 
another and developing predictors, such as polygenic risk scores, require well-matched 
7 
 
population samples. Sampling bias should also be considered: ascertainment approaches and 
inclusion and exclusion criteria can limit the representativeness of the sample and the 
applicability of the results to the general population. For example, gender, ethnicity, type of 
disorder, age, geography, and socioeconomic status should all be considered when designing 
ascertainment strategies. 
 
2.1 Twin-based heritability (Twin-h2) 
Twin-based h2 estimates are derived from the phenotypic similarity (i.e., phenotypic 
correlations) between monozygotic (identical twins) and dizygotic twins (fraternal twins), their 
known proportion of shared genomes (100% and 50%, respectively), and their expected shared 
environment (Rijsdijk & Sham, 2002). The standard ACE twin model (Figure 1) captures the 
relative contribution of additive genetic (A), common environmental (C), and unique 
environmental (E) factors on trait variation. Importantly, in standard twin models, these are not 
measured, but rather inferred. The proportion of variance of a trait accounted for by A, C, and E 
is equal to the square of the connecting paths (a, c, and e, respectively). In this model, a2 
represents the h2 estimate, c2 captures the variance of the shared environmental factors (all 
factors that serve to make twins similar), and e2 captures the variance of all factors that serve to 
make twins different and includes error of measurement (Figure 1). 
Twin-based h2 (twin-h2 or a2) estimates of most behavioral traits (including eating 
disorders) fall roughly between 30% and 80% (Polderman et al., 2015). Twin-h2 estimates are 
influenced by several factors including: a) how the trait under investigation is measured, b) trait 
prevalence, c) the population, d) sex, e) developmental stage or age, f) time of measurement, and 
g) geographical area (Visscher et al., 2008). Therefore, h2 estimates for the same trait do and are 
expected to differ across studies, across populations, and across time. 
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2.2 Single nucleotide polymorphism-based heritability (SNP-h2) 
The h2 contributed by common genetic variation can be calculated from genotype data 
from SNP arrays or GWAS summary statistics (SNP-h2; Yang, Zeng, Goddard, Wray, & 
Visscher, 2017). Modern methods for estimating SNP-h2 include genome-wide complex trait 
analysis (GCTA; Yang, Lee, Goddard, & Visscher, 2011) and linkage disequilibrium (LD) score 
regression (LDSC; Bulik-Sullivan et al., 2015). GCTA derives estimates by comparing the 
degree to which individuals share their genomes to their similarity on a particular trait. LD score 
regression estimates h2 from regressing the association statistics for SNPs against their summed 
correlation with nearby SNPs (for further details, see Yang et al., 2017). 
As mentioned previously, estimates of SNP-h2 are typically and expectedly lower than 
twin-h2 estimates. This has held true in twin studies in eating disorders and other psychiatric 
disorders (Table 1; Anttila et al., 2016; Cross-Disorder Group of the Psychiatric Genomics 
Consortium et al., 2013). The SNP-h2 for anorexia nervosa (AN) is ~20% (Duncan et al., 2017) 
in comparison to twin-h2 estimates ranging from 28% to 74% (Bulik et al., 2006, 2010; Dellava 
et al., 2011; Klump et al., 2001; Kortegaard et al., 2001; Mazzeo et al., 2009; Wade et al., 2000). 
This differential is consistent with other complex traits and is likely due to fundamental 
differences in what each measure captures. Whereas SNP-h2 captures h2 due primarily to 
common variation, twin-h2 also captures h2 due to rare genetic variations (mutations) as well as 
passive, evocative, and active gene-environment correlations (McAdams et al., 2014), and gene-
environment interactions (Vinkhuyzen & Wray, 2015). It is important to note, however, that 
although h2 estimates are a central outcome of twin studies, the goals of GWAS, in contrast, 
reach far beyond h2 estimates and rather seek to identify actual causal variants that affect disease 
risk. 
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3. Core Methods in the Genetics of Eating Disorders 
 
3.1 Family history and family studies 
 The familial aggregation of AN, bulimia nervosa (BN), and binge-eating disorder (BED) 
have been widely documented and replicated (Hudson et al., 2006; Javaras et al., 2008; Kassett 
et al., 1989; Lilenfeld et al., 1998; Mangweth et al., 2003; Stein et al., 1999; Strober, Freeman, 
Lampert, Diamond, & Kaye, 2000, 2001; Strober et al., 1990; Strober, Morrell, Burroughs, 
Salkin, & Jacobs, 1985). In their most basic form, family studies are designed to determine 
whether a trait or disorder “runs in families”. The “family history” method in which one or a few 
family members act as informants about the status of other family members is less effortful but 
also less informative than the family study method (Hudson, Pope, Jonas, & Yurgelun-Todd, 
1983; Hudson, Pope, Jonas, Yurgelun-Todd, & Frankenburg, 1987; Keck et al., 1990; Rivinus et 
al., 1984). In the “family study” method, every family member is queried or interviewed about 
their own history (and can also serve as an informant on other family members). Although 
methods do exist to determine the extent to which genes affect the familial aggregation of a trait 
or illness from a family study (Hudson et al., 2006; Javaras et al., 2008; Kassett et al., 1989; 
Lilenfeld et al., 1998; Mangweth et al., 2003; Stein et al., 1999; Strober et al., 2000, 2001, 1990, 
1985), they are more effective in identifying the existence of familial aggregation rather than the 
extent to which genetic or environmental factors cause that aggregation (Visscher et al., 2008). 
 Population level family studies compare the overall population prevalence with the 
disease risk of family members with an index case in their family (a proband) and yield relative 
risk estimates taking into account the relationship to the proband (McGuffin & Burke, 2014). For 
instance, siblings of individuals with AN were four times more likely to suffer from AN than 
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siblings of unaffected control probands in a Danish nationwide registry study (Steinhausen, 
Jakobsen, Helenius, Munk-Jørgensen, & Strober, 2015).  
 More sophisticated family designs can also be conducted in large populations when 
different degrees of relatedness in multigenerational registers are used to tease apart genetic and 
environmental factors whilst controlling for genetic confounding of these environmental factors 
(i.e., gene-environment correlations). For example, a child may grow up in an environment 
where both parents smoke: the parents will most probably have passed on variants of genes 
which make the child more likely to smoke but may also create a family environment where the 
child is exposed to smoking behavior and second hand smoking (i.e., passive gene-environment 
correlation). The child may actively choose its environment where its peers smoke (i.e., active 
gene-environment correlation) and then may ask for cigarettes and receive them (i.e., evocative 
gene-environment correlation; Narusyte et al., 2008). In this design, multigenerational registers 
that can specify different family relationships between individuals who share known and varying 
proportions of genetic factors and environmental factors (Figure 2). Comparing the degree of 
genetic relatedness and similarities of the trait or disorder over several generations—both 
expressed in correlations—allow the researcher to make cautious causal inferences and estimate 
the relative contribution of genetic and environmental factors (D’Onofrio, Lahey, Turkheimer, & 
Lichtenstein, 2013). 
 
3.2 Twin studies 
 After verifying familial aggregation of a trait or disorder in family studies, the next 
logical step is to determine the extent to which the observed familiality is due to genetic or 
environmental factors. Twin studies are an approach to address this question and were the 
mainstay of genetic epidemiology for decades (Figure 1). Encouragingly, estimates of the genetic 
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and environmental contributions to eating disorders represent robust findings in our field 
(Polderman et al., 2015). Twin studies conducted on patients with eating disorders in European-
ancestry populations yielded h2 point estimates ranging from 28% to 74% for AN, from 55% to 
65% for BN, and from 33% to 45% for BED (Baker et al., 2010; Bulik et al., 2006, 2010, 1998; 
Dellava et al., 2011; Javaras et al., 2008; Klump et al., 2001; Kortegaard et al., 2001; Mazzeo et 
al., 2009, 2010; Mitchell et al., 2010; Trace et al., 2013; Wade et al., 2000). Due to the low 
prevalence of the disorders and thus relatively few cases in twin registries, most estimates have 
fairly wide confidence intervals (Yilmaz et al., 2015). 
 The validity of twin results rest on several important assumptions. First, twin studies 
assume that identical (monozygotic or MZ) twins are 100% genetically identical, whereas 
fraternal (dizygotic or DZ) twins share on average 50% of their segregating alleles (i.e., version 
of genes inherited from their parents; Rijsdijk & Sham, 2002). As our ability to query the 
genome advances, it is becoming clear that minor genetic and epigenetic differences do exist 
between MZ twins (Bruder et al., 2008; Charney, 2012; Wong et al., 2010); however, the impact 
of these differences on results is minimal (Liu, Molenaar, & Neiderhiser, 2017). Second, twin 
studies assume that environmental factors of relevance to the trait under investigation are shared 
equally between MZ and DZ twins (i.e., the equal environments assumption or EEA). Two large 
studies tested the EEA by, first, correcting twin-h2 estimates by a measure of similarity between 
twins (Felson, 2014) and, second, by investigating the similarity between twins who had been 
falsely assigned as DZ when they were actually biologically MZ (Conley, Rauscher, Dawes, 
Magnusson, & Siegal, 2013). Neither approach revealed a gross violation of the EEA. Third, 
twin studies assume that the prevalence of trait under investigation is similar in twins as in the 
general population. For example, one study reported a 1.5-fold greater prevalence of AN in twins 
than in singletons in Sweden (Goodman, Heshmati, Malki, & Koupil, 2014). Although this 
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observation requires replication, it highlights the importance of comparing prevalences in twins 
relative to the general population to ensure that twin-specific risk factors are not operative. 
 
3.3 Candidate gene studies 
Candidate gene studies should be viewed in their historical context, which was limited by 
the fact that large scale genotyping arrays that concurrently measure several million genetic 
markers only became available and affordable in the last decade. In the candidate gene approach, 
a researcher chooses one or a few genes (i.e., extremely low coverage of the genome) that they 
hypothesize could contribute to eating disorders and compares the frequency of the variants of 
that gene in a sample of cases versus a sample of controls. Due to the many shortcomings of the 
candidate gene studies, they have fallen out of favor as an approach to the initial identification of 
genes involved in the etiology of psychiatric disorders (Duncan & Keller, 2011; Vinkhuyzen & 
Wray, 2015). Candidate gene studies are limited by pre-existing knowledge about the trait under 
study and about the selected genes, are physically limited to loci within and near genes (e.g., 
promoter, coding regions, and introns), and have typically been grossly underpowered. In 
addition, the same subtle biases that can affect genome-wide studies such as cryptic relatedness 
and population stratification can affect candidate gene studies.  
In eating disorders, the selection of candidate genes was based on educated guesses about 
the biology of eating disorders (e.g., genes related to serotonin which is known to influence both 
appetite and mood). Knowing now that complex traits such as eating disorders are likely to be 
influenced by hundreds if not thousands of genes, it is understandable that these complex 
behavioral syndromes could not be explained via the function of one or a few genes. Many of the 
samples collected during the candidate gene era have been meaningfully carried forward to 
genome-wide studies. Current standards dictate that candidate gene studies should only be 
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employed to replicate findings from existing GWAS and never as an initial step in genetic 
analyses. No candidate gene study of eating disorders has ever produced robust and reproducible 
findings (Yilmaz et al., 2015). 
 
3.4 Linkage studies 
The fundamental premise of linkage studies is based on the observation that the genetic 
variants in genes that reside physically close on a chromosome remain linked during meiosis 
(i.e., specialized type of cell division to create germ cells) and tend to do so over several 
generations if those variants are close together. Linkage analysis allows the assessment of the 
strength of linkage between genetic variants characterizing a region and disorder or disorder 
status in families. In particular, this methodology is favored for the detection of large effect 
genetic mutations, especially those that have sufficient penetrance to cause observable dominant 
or recessive inheritance of disorders. We now know that such examples are rare in psychiatric 
disorders, [although they do exist, such as the chromosome 1:11 translocation in schizophrenia 
(St Clair et al., 1990)]. However, linkage studies conducted on AN and BN examining affected 
relative pairs have by and large not yielded robust or reproducible findings (Bacanu et al., 2005; 
Bergen et al., 2003; Bulik et al., 2003; Devlin et al., 2002; Grice et al., 2002). 
 
3.5 Genome-wide association studies (GWAS) 
GWAS is currently the workhorse of psychiatric genetics, and, as the name implies, is a 
genome-wide approach. Unlike candidate gene studies, a GWAS employs millions of markers 
across the genome and compares their frequency between cases and controls for binary traits, or 
their correlation with a trait, such as BMI, in a population. Sample sizes are usually large—in the 
tens or even hundreds of thousands. Given the sheer number of comparisons, most of the results 
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that cross the nominal association threshold of 0.05 do so by chance—so rigorous control for 
multiple testing must be employed. There are approximately 10-8 independent tests involved in a 
GWAS. Consequently, the Bonferroni multiple testing corrected p-value of 5x10-8 is regarded as 
genome-wide significant, which is crucial for rigor in GWAS (Dudbridge & Gusnanto, 2008; 
Risch & Merikangas, 1996). Given this stringent threshold, many true associations remain 
nonsignificant often due to practical limitations in power, which is dependent on sample size and 
allele frequencies of variants of interest in the sample.  
 Very large sample sizes are required to achieve adequate statistical power for the 
detection of variants within the expected effect size range for complex disorders, usually 
between odds ratios (OR) of 1.0 and 1.2 in case-control studies (Park et al., 2011; W. Y. S. 
Wang, Barratt, Clayton, & Todd, 2005). Although researchers used to larger effect sizes may 
find these to be small, they must be interpreted in the context of the polygenic model of complex 
traits in which thousands of genes in concert influence a phenotype. Interpreting GWAS effect 
sizes in the tradition of Cohen inevitably leads to false conclusions, results in misinterpretation, 
and premature rejection of results (Chen, Cohen, & Chen, 2010). Sample size is the critical 
ingredient for GWAS success and can be estimated using publicly available power calculators 
(Purcell, Cherny, & Sham, 2003; Sham & Purcell, 2014). The Psychiatric Genomics Consortium 
(PGC) has facilitated achieving required sample sizes in the tens to hundreds of thousands by 
facilitating unprecedented international collaborations (Sullivan et al., 2018). Research in 
schizophrenia and major depressive disorder has revealed a nearly linear relationship between 
the number of detected genome-wide significant regions (i.e., associations) and increases in 
sample size (Hyman, 2014). Current goals of the PGC are to achieve sample sizes of 100,000 for 
each major psychiatric disorder, including eating disorders. 
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Such collaboration also enabled the identification of the first genome-wide significant 
locus for AN by the Eating Disorders Working Group of the PGC. The locus on chromosome 12 
has been previously implicated in a range of autoimmune disorders, such as rheumatoid arthritis 
and type 1 diabetes (Duncan et al., 2017). Until now, no GWAS of BN or BED have been 
conducted, but sample collection is underway. 
Other factors that are important in evaluating GWAS include the screening of controls for 
the disorder or trait under study, especially if the disorders are common in the population, as well 
as for strongly correlated phenotypes. The rationale for this is a control group that contains a 
large proportion of cases decreases the statistical power to detect the association of a genetic 
variant with the disorder. Ancestry, relatedness, population stratification, and reliable phenotype 
assessment are crucial in GWAS (see section 4) and should be carefully considered in the study 
design. Extensive quality control is applied to genotype data: data sets are checked for 
genotyping quality (i.e., SNP and individual missingness); expected frequencies of the alleles in 
the population (i.e., deviation from Hardy-Weinberg equilibrium); and, if imputed, for 
imputation quality (i.e., INFO score; for detailed information see Coleman et al., 2016). Finally, 
replication of identified associations between genetic variants and a disorder should be pursued 
in an independent data set, which is often difficult due to the large sample sizes required for 
GWAS, but will become easier with the emergence of large biobanks. 
The interpretation of GWAS results is complicated as common variant association signals 
can come from loci well outside of any known genes and from loci that are hard to annotate 
functionally or understand their precise role in the disorder. If a genomic region associated with a 
trait harbors genes, it may well be more than 30 genes, making the selection of which to carry 
forward in animal or organoid models challenging (Sekar et al., 2016). Estimates show that it is 
possible to create a hypothesis from about 80% of the associated and annotated genes in GWAS 
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underscoring the problem of gene selection (Hawrylycz et al., 2012). Additionally, identified 
genomic regions can interact with genes that are located further away on the same or other 
chromosomes. Genetic variants located within the alpha-ketoglutarate dependent dioxygenase 
(FTO) gene, for instance, are robustly associated with type 2 diabetes and obesity; however, 
these genetic variants interact with iroquois homeobox 3 (IRX3) which is several hundred 
thousand base pairs away from FTO due to complicated folding structures of the human 
chromosomes. IRX3 appears to be the gene most strongly affecting BMI (Claussnitzer et al., 
2015; Smemo et al., 2014). Genetic variants that are very far away from implicated genes—not 
just neighboring genes—can have surprisingly strong effects on the observed phenotype.  
 
3.6 Follow-on approaches 
 A common question raised after loci are identified via GWAS is: “What next?” This is a 
complex question worthy of its own paper, and indeed several authors have addressed the 
question extensively (de Leeuw, Neale, Heskes, & Posthuma, 2016; Maier, Visscher, Robinson, 
& Wray, 2017; Yang et al., 2017). GWAS results can be prioritized and carried forward into 
systematic analyses including polygenic risk scoring (PRS), SNP-based genetic correlations, and 
pathway analyses in order to estimate genetic liabilities, identify genetic overlap between traits, 
understand extended biological pathways, and inform studies of functional biology, such as 
animal, cell, and organoid studies. These follow-on approaches combine many SNPs of small 
effect to capture the polygenic nature of complex traits. For our purposes in addressing rigor and 
reproducibility in eating disorders genetics, we will focus on a few widely employed methods. 
Reproducibility in animal (Peers, South, Ceuppens, Bright, & Pilling, 2014) and cell studies 
(González, Boué, & Izpisúa Belmonte, 2011; Maherali & Hochedlinger, 2008; Young-Pearse & 
Morrow, 2016) are reviewed elsewhere. 
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3.7 Polygenicity: polygenic risk scoring 
The results generated by GWAS (i.e., summary statistics) contain a plethora of 
information. In addition to significant loci, genomic regions below the genome-wide significance 
threshold of 5x10-8 also carry valuable information. To capture the full polygenic signal, one can 
calculate PRS with software such as PLINK (Chang et al., 2015) or PRSice (Euesden, Lewis, & 
O’Reilly, 2015). A PRS is the sum of the genetic risk alleles carried by an individual, 
multiplied/weighted by their effect size. The effect sizes are determined from the largest 
available discovery GWAS. For instance, assume that A represents the risk allele at a given 
locus. As all individuals carry two alleles at the same locus, they can either carry two risk alleles 
(AA), one risk allele (A and T), or no risk alleles (TT). The risk allele “count” in the locus is 
then multiplied by the effect size (i.e., odds ratio or beta) and all risk loci are summed to form the 
total PRS value. The higher the PRS, the more risk variants an individual carries. For a practical 
guide see (Maier et al., 2017). PRS can be incorporated into regression analyses as predictors of, 
for example, case status, treatment outcome, or disorder severity (Figure 3).  
PRS prediction studies require independent discovery and target samples. Summary 
statistics from a GWAS for a trait or disorder in the discovery sample are used to create the PRS, 
which is then applied to individuals in the target sample. In a regression model, we can then test 
how well the PRS derived from the discovery sample predicts case status in the target sample.  
Rigorous application of PRS should ensure that the discovery and target samples are truly 
independent, with the same individuals or close relatives not represented in both samples. In 
addition, genetic variants in close physical proximity are not independent and therefore must be 
clumped to a single marker (Dudbridge, 2013, 2016; Wray et al., 2013, 2014). Inclusion of 
correlated markers would lead to overfitting of the model and inflate the association between 
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PRS and trait. It is also important to use two samples stemming from the same ancestry group 
and to correct for population stratification within these groups (see below). Furthermore, it is 
important to determine the genome-wide significance threshold that should be used to decide 
which genetic markers to include in the PRS. This can be achieved by fitting regression models 
at different genome-wide significance thresholds. This method, however, is subject to multiple 
testing because fitting a regression at every p value threshold represents a statistical test. This can 
be solved by permutation (Phipson & Smyth, 2010).  
PRS need to be interpreted on the population level, meaning the absolute value of an 
individual's PRS needs to be compared with the PRS of the rest of the population. The 
distribution of PRS, therefore, is often divided into deciles. Furthermore, PRS should not be 
interpreted deterministically. Even though an individual may carry a substantial number of 
genetic risk variants (i.e., have a high PRS), they may never develop a disorder due to either 
protective environmental factors, absence of exposure to environmental triggers, or other genetic 
factors that could contribute to resilience. The opposite can also occur: an individual with a low 
PRS may develop a disorder because of adverse environmental exposures or other genetic factors 
that influence risk. 
Other applications of PRS exist. PRS can be incorporated into imaging genetics to 
investigate the relationship between an individual's polygenic load and brain structure (Dima & 
Breen, 2015). PRS can also be used to investigate gene x environment interactions. For example, 
Agerbo et al. (2015) discovered a positive G x E interaction for schizophrenia where a higher 
schizophrenia PRS interacted with a positive family history increasing liability for the 
psychiatric disorder. However, this finding requires replication in a larger independent sample. 
Furthermore, genome-wide by environment interaction studies (GWEIS) can measure gene x 
environment interactions. For example, an interaction between stressful life events and genetic 
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variants associated with depressive symptoms has been reported (Dunn et al., 2016) and another 
larger investigation in the UK Biobank revealed an interaction between self-reported traumatic 
experiences and genetic variants associated with depression (Coleman, Major Depressive 
Disorder Working Group of the Psychiatric Genomics Consortium, UK Biobank Mental Health 
Consortium, Eley, & Breen, 2018). However, both findings also require replication. 
 
3.8 Pleiotropy: genetic correlations 
Pleiotropy (i.e., the extent to which genetic variants influence two or more traits) is 
common in genetics and may explain the frequent co-occurrence of specific traits and disorders 
(i.e., comorbidity). The calculation of SNP-based genetic correlations (rg) from GWAS summary 
statistics is one way to determine the extent to which disorders or traits share causal genetic 
variants. Like other correlations, SNP-based rg have values between 0 and 1 and can be either 
positive or negative. A positive rg indicates that the same genetic variants influence both traits in 
the same direction, and a negative rg indicates that the same genetic variants influence both traits, 
but in opposite directions. For example, significant rg from the latest AN GWAS, revealed a 
positive rg between AN and schizophrenia and between AN and a cross disorder phenotype from 
the PGC, both confirming that AN is genetically related to other psychiatric disorders (Duncan et 
al., 2017). Intriguingly, a palette of significant positive genetic correlations emerged with 
favorable metabolic parameters (high density lipoprotein measures), and a parallel palette of 
negative genetic correlations with what are considered to be unfavorable metabolic parameters 
(insulin and glucose-related parameters). In addition, AN was negatively genetically correlated 
with BMI and obesity measures. Together these observations provide insight to the manner in 
which shared genetic variants influence AN and other psychiatric and metabolic/anthropometric 
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traits and underscore the importance of addressing metabolic as well as psychiatric aspects of the 
illness.  
 
3.9 Biology: pathway analyses 
 Methods developed in systems biology allow us to discern functional pathways that are 
activated in eating disorders. Genes rarely function entirely independently, but rather are 
embedded in a highly complex network of pathways that interact with each other leading to 
downstream effects. Molecular components that are parts of reactions, such as nucleic acids and 
proteins, build networks of biological interactions and are grouped into pathways within those 
databases. Examples of these biological pathways are innate immune function, apoptosis, and 
neurotransmitter signaling. 
 Pathway analysis reduces the number of tests conducted by grouping genes into 
pathways; however, correction for multiple comparisons remains necessary. An extensive review 
on pathway analyses can be found by Kao et al. (2017). Although the current AN GWAS was 
underpowered to detect significant pathways associated with the disorder, larger sample sizes 
will lead to more robust signals and will facilitate future pathway analyses (Duncan et al., 2017). 
Pathway analysis results have the potential to reveal tissues that are relevant to the disorders, can 
inform downstream cell and animal studies that are designed to further explicate the biology of 
the illness or aspects of the illness, and can inform pharmacologic targets for interventions.  
 
3.10. Drug repurposing and development 
If evidence emerges for a specific drug-related pathway from a genome-wide study, the drug is 
more likely to show efficacy in the treatment of the disorder under study (Nelson et al., 2015). 
GWASs have already demonstrated the ability to identify and confirm previously known drug 
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targets, such as the dopamine receptor D2 for schizophrenia, the common target of antipsychotic 
medications (Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium, 
2011). The genetic signal from GWAS, therefore, can be used as part of a drug discovery or drug 
repurposing pipeline to prioritize drug targets and their binding partners (Gaspar & Breen, 2017). 
 
4. Factors to Consider When Evaluating Rigor and Reproducibility of the Genetics of 
Eating Disorders  
 
4.1 Phenotype 
A phenotype is the set or a subset of the observable characteristics of an individual. The 
validity and reliability of the phenotype studied is an important factor to consider in evaluating 
the genetics literature. In eating disorders genetics, many different phenotypes have been 
employed. In the absence of biomarkers or laboratory values that reliably index the presence or 
absence of an eating disorder, the most valued phenotype in research has been a diagnosis 
conducted via a structured clinical interview, by a trained clinician. Even though the structured 
clinical interview was the benchmark against which all other phenotypes were measured, it is 
still subjective, not perfectly reliable, and a potential source of error in genetic studies of eating 
disorders. This approach is also impractical and expensive for large studies. Moreover, 
diagnostic flux across eating disorder presentations is well-documented and reduces the 
reliability of eating disorders diagnoses (Castellini et al., 2011; Eddy et al., 2008; Ekeroth, 
Clinton, Norring, & Birgegård, 2013; Milos, Spindler, Schnyder, & Fairburn, 2005).   
 Other methods that capture diagnostic phenotypes include clinical records, national 
patient registers, self-report of ever having had an eating disorder, parent report, and self-report 
of symptoms that are combined through an algorithm into a diagnosis. Each of these has 
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advantages and disadvantages that should be considered carefully. The measurement of a 
phenotype should be also considered when evaluating reproducibility, as different ways to define 
an eating disorder can measure slightly different characteristics or phenotypes, which in turn 
affects the variants we discover. 
 With statistical power always being a critical consideration, and the prevalence of eating 
disorders being fairly low, diagnostic categories have often been relaxed in order to increase the 
number of available cases. This boost in sample size, however, could theoretically hamper gene 
discovery for the intended phenotype, as we might sample a more heterogeneous sample. For 
example, the twin-h2 of AN decreases as diagnostic criteria broaden (Dellava et al., 2011).  
 Even more common is the use of self-report questionnaires that capture dimensions 
purported to be relevant to the etiology of eating disorders such as body dissatisfaction, dietary 
restraint, drive for thinness, etc. In reality, we have no idea whether these constructs index the 
same underlying biology/genetics that the core diagnoses of AN, BN, and BED do. Yet we often 
assume that we are speaking about highly related constructs. Some of the methods outlined 
above such as computing SNP-based rg between these continuous phenotypes and eating 
disorders diagnoses will allow us to address this question directly. 
 Other approaches to consider include incorporating continuous dimensions from the 
Research Domain Criteria (RDoC) model to measure domains relevant to eating disorders such 
as reward, inhibition, and social communication (Wildes & Marcus, 2015) and incorporating 
objective measures including, for example, biomarkers, digital phenotyping, and accelerometer 
measurements to improve measurement precision and reduce error.  
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4.2 Relatedness 
If the researcher is conducting a genetic case-control association study comparing the 
genomes of cases to the genomes of controls, and several related individuals are in the case 
sample, the sample might be biased enough to cause trouble (see Box 2).  
 
Box 2: Potential Impact of Relatedness 
Imagine that John hears about a genetic study of AN and given his history of the illness, 
decides to participate by donating a blood sample for DNA. At a holiday gathering, he tells his 
three siblings and all 21 of his cousins about the study. Although none of them has talked 
openly about their eating disorder, seven of them have had AN, and they all go home, login, 
and sign up for the study.  
 
The fact that related individuals share large proportions of their segregating alleles (i.e., 
genomes) on average (e.g., identical twins 100%; full siblings on average 50%; first cousins on 
average 12.5%) increases the likelihood that related individuals carry the same genetic alteration 
at a certain genomic locus (Figure 2; Astle & Balding, 2009). If a sample includes cryptic 
relatedness, any observed genetic differences between cases and controls could actually be due to 
relatedness rather than the eating disorder phenotype under investigation. Control for this can be 
achieved calculating a relatedness matrix from a genome-wide marker data that estimates the 
degree of relatedness between individuals in the data set. These estimates can be included in the 
statistical model, which controls for their genomic similarity and enables the researcher to retain 
the participants (Hellwege et al., 2017). Another approach is to exclude related individuals (i.e., 
individuals who share more than 0.03%, such as second cousins or the grandchild of a cousin) 
from all analyses (Coleman et al., 2016). 
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4.3 Population stratification and leveraging diverse populations 
Population stratification refers to systematic differences in allele frequency at certain 
positions throughout the genome in groups of individuals that are ancestrally from different 
geographical locations. When an undetected or unaccounted for systematic bias in allele 
frequencies between populations coincides with systematic difference in a phenotype under 
investigation, it can cause false positive or negative results (Box 3; Hellwege et al., 2017). 
 
Box 3: Example of Population Stratification 
One classic example of an association caused by population stratification is that of the genetic 
variant encoding increased lactase persistence into adulthood with height. Lactase persistence 
refers to the continued activity of the lactase enzyme which is responsible for digesting lactose 
in milk into adulthood. In most mammals (including humans), the activity of lactase is 
dramatically reduced after weaning. In humans this results in lactose intolerance. 
Epidemiologically, both height and lactase persistence increase towards Northern Europe, 
although there is no causal relationship between the two traits. Therefore, if one analyses 
people of European ancestry without taking into account their region of origin, the lactase 
persistence variant and height appear to be associated. If one properly matches cases and 
controls by their ancestry, e.g., Greeks with Greeks and Scandinavians with Scandinavians, the 
association disappears.  
 
Most researchers are aware of the threat of population stratification when comparing broader 
ancestral groups (e.g., Africans, Asians, Europeans, Native Americans, etc.), but population 
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stratification can even obscure results within the same continent or country, if ancestry is not 
properly accounted for (Marchini, Cardon, Phillips, & Donnelly, 2004). 
Population stratification reflects drift (i.e., random chance of alleles being dropped out or 
being enriched in a population), bottlenecks (i.e., a small ancestral population at any time point 
in the population’s history), and non-random mating (i.e., you are more likely to mate with 
someone who lives near you and is ancestrally similar to you; Price, Zaitlen, Reich, & Patterson, 
2010). Even in this highly mobile world, the pattern is remarkably visible in our genomes. An 
all-European investigation by Novembre et. al. (2008) basically recreated the geographical map 
of Europe by projecting genetic similarity between study participants onto a two-dimensional 
space (Figure 4).  
Most studies now use principal components to correct for ancestry effects by including 
ancestry principal components as covariates (Hellwege et al., 2017; Pritchard, Stephens, & 
Donnelly, 2000; Y. Zhang, Shen, & Pan, 2013). Although large ancestrally homogeneous 
samples are powerful, including individuals from diverse ancestral backgrounds can increase the 
power of a genetic study (Pulit, Voight, & de Bakker, 2010). Statistical simulations comparing 
European-only with diverse ancestry GWAS showed that multiethnic samples increase power 
especially for the detection of variants with frequencies lower than 5% (Pulit et al., 2010). Thus, 
admixed populations may be another powerful and underused resource for genetic studies (J. 
Zhang & Stram, 2014). 
 
 
4.4 Sample size 
 Large sample sizes are clearly essential to GWAS success, but the question of how big is 
big enough is highly relevant to eating disorder genetic rigor and reproducibility. For each 
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psychiatric disorder, genomic discovery has accelerated as sample size has increased. The 
current goal of the PGC is to achieve sample sizes of 100,000 for each of the ten disorders under 
study. However, the optimal sample size depends to a large extent on the genetic architecture of 
the illness under study. Figure 5, presents the discovery trajectory that can be expected in 
complex traits such as eating disorders (adapted from Sullivan et al., 2018). This curve illustrates 
the “dead zone” when sample sizes are inadequate for discovery of significant hits, through 
sample-size-induced acceleration of discovery, to the ultimate asymptote. The PGC recommends 
striving for a “good enough” point where “most genes are identified at least once and the 
majority of genes in salient biological processes are highlighted” (Sullivan et al., 2018). With 
this in mind, it is clear that statistical power in the initial two AN GWAS (Boraska et al., 2014; 
K. Wang et al., 2011) occupied the dead zone. Combining these efforts and adding new samples 
has edged eating disorders genetics into the discovery phase; however, many more samples are 
needed in order to reach the “good enough” point.  
 A point worth considering is that an individual’s genome has one extraordinary 
advantage, namely stability over time. A given individual has to be sampled and genotyped only 
once and the resultant data can then be used repeatedly to address a host of research questions. 
For example, if an individual was a regular heavy smoker and had bulimia nervosa, their 
genotype data could contribute to both a smoking and a bulimia nervosa GWAS. Given the need 
for large samples for genomic discovery, mega-analytic and meta-analytic approaches are 
common and appropriate methods to combine GWAS data from large international consortia. 
Such approaches are even more essential in the search for rare variants (Evangelou & Ioannidis, 
2013; Lin & Zeng, 2010; Sung et al., 2014). Heterogeneity, however, can be introduced from 
various sources, including phenotype definition, the inclusion of individuals from diverse 
ancestral groups, and different genotyping platforms or imputation software. Well designed 
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meta- and mega-analyses take these issues into account and address them appropriately 
(Evangelou & Ioannidis, 2013).  
 
5. Rare variation and copy number variants 
The genetic architecture of a trait comprises all genetic variants, their effect sizes, 
frequencies, interactions with each other, and with environmental factors through epigenetic 
factors (Timpson, Greenwood, Soranzo, Lawson, & Richards, 2018). Rare variants (i.e., present 
in less than 1% of the population) can also contribute to etiology and can be investigated via 
whole-genome (WGS) or whole-exome sequencing (WES). In schizophrenia, this approach 
identified genetic variants that were not captured by GWAS and are assumed to be etiologically 
relevant (Richards et al., 2016). WGS, however, is still a costly (around $2,000 per genome) and 
therefore not yet affordable for large-scale epidemiological studies (Schwarze, Buchanan, 
Taylor, & Wordsworth, 2018; Timpson et al., 2018). If we assume that rare variants are present 
in about 1% of the population, in an optimal scenario, we would need to sample 1,000 cases to 
identify 10 carriers, which should be compared to at least 1,000 controls. This may require even 
larger sample sizes than GWAS. Copy number variants (CNVs) are large-scale structural 
changes of the genome that span more than 1 kb (i.e., 1000 base pairs), including insertions, 
deletions, and duplications. Most CNVs are inherited, but some arise de novo (Thapar & Cooper, 
2013). Carriers of large, rare, pathogenic CNVs often show profound phenotypes including 
intellectual disability and malformations, rendering them unlikely candidates for eating disorders 
if not accompanied by other severe clinical manifestations. However, it is possible that smaller 
CNVs that are more difficult to analyze with current methods could still be relevant for eating 
disorders. Investigations of CNVs in AN have showed no association so far (Yilmaz et al., 
2017), but efforts are currently underway on larger sample sizes.  
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6. Epigenetics 
Epigenetics investigate mechanisms of gene regulation that are hypothesized to mediate 
the interaction of our genome with environmental stimuli. Three types of epigenetic 
modifications have been described: methylation, histone modifications, and non-coding RNAs. 
A comprehensive review on epigenetic modification and their mechanisms can be found at 
(Bartel, 2009; Roadmap Epigenomics Consortium et al., 2015). All three modifications change 
the accessibility of DNA and enable or disable the translation of certain DNA segments into 
proteins. Epigenetic research in eating disorders has not yet yielded consistent findings. 
Methylation is the only epigenetic modification to have been studied and most studies focused on 
AN. Very small sample sizes have hampered interpretation and replication. For the future, 
longitudinal epigenome-wide association studies (EWAS) that control for environmental 
confounders, such as sex, age, smoking, alcohol consumption, medication, and diet, and that 
include thousands of eating disorder cases, will complement other genetic approaches. A 
comprehensive review of epigenetics is beyond the scope of this article, but can be found 
elsewhere (Hübel, Marzi, Breen, & Bulik, 2018; Thaler & Steiger, 2017). 
 
 
7. Conclusion 
Intensifying the search for contributing genetic factors in eating disorders is essential not 
only to explicate the biological causal mechanisms underlying the illnesses, but also to improve 
our ability to understand why environmental factors differentially influence individuals. We 
acknowledge the important role of environment in the etiology of eating disorders. Indeed, the 
contribution of environment is inherent in the fact that eating disorders are not 100% heritable. 
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One advantage of lagging behind other disorders in terms of progress in psychiatric genetics, is 
that teams working on other conditions such as schizophrenia and major depressive disorder, 
have paved the way by developing and refining methodologies and analytic strategies. This 
focuses our efforts on amassing adequate sample sizes to enable the identification of underlying 
biological processes. Rigorous genetic investigations will not only improve our understanding of 
the molecular biology of eating disorders, but will also allow us to identify resilience and risk 
factors involved in the complex interplay of genetics, development, and a multitude of 
environmental factors implicated in eating disorders (Wray et al., 2014). Poorly conducted 
analyses, inaccurate interpretations, and overly optimistic reporting of spurious associations can 
lead to a waste of resources and distort our understanding of the biological mechanisms for years 
to come (Henriksen, Nordgaard, & Jansson, 2017). Reliable and replicated results, in contrast, 
will stimulate follow-on research that will lead to better understanding of the illnesses and 
ultimately improvement of prevention and intervention for individuals with eating disorders. In 
the long run, the confident identification of genes and pathways implicated in eating disorders 
etiology will enable the repositioning of available medications and even the development of 
novel medications to alleviate symptoms or target causal or maintaining mechanisms in eating 
disorders (Breen et al., 2016). 
In addition, being able to quantify genetic risk through the use of PRS and other 
techniques not yet developed, may improve our ability to determine individual risk, compare 
environmental effects between high- or low-risk individuals with and without eating disorders to 
identify triggering and/or protective environmental effects, offer preventative interventions (if 
appropriate), be more vigilant for early symptoms in high-risk individuals, and inform 
personalization of treatment. We underscore that genetic risk is only one factor in determining 
whether an individual develops a given illness. Even someone with a high PRS for AN may 
30 
 
never develop the illness (e.g., due to other resilience or protective genes and/or under favorable 
environmental conditions). Likewise, someone with low genetic risk could develop AN for other 
reasons (e.g., other genetic risk factors or high burden of adverse environmental exposures). 
Ultimately, the goals of genetic research are to deliver rigorous “actionable” findings for eating 
disorders, defined as genomic results that 1) reveal the fundamental biology of the illnesses, 2) 
inform clinical practice, and 3) deliver new therapeutic targets (Sullivan et al., 2018). 
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Table 
 
Table 1. Heritability (h2) estimates derived from different genetic study designs for other 
psychiatric disorders and eating disorders (Sullivan et al., 2018; Yilmaz et al., 2015). 
Disorder Twin-h2 Family-h2 SNP-h2 
Other psychiatric disorders 
Schizophrenia 81% (Sullivan, 
Kendler, & 
Neale, 2003) 
64% (Lichtenstein et 
al., 2009) 
45% (Schizophrenia 
Working Group of the 
Psychiatric Genomics 
Consortium et al., 
2014) 
Bipolar disorder 68% (Polderman 
et al., 2015) 
55% (Song et al., 
2015) 
21% (Psychiatric 
GWAS Consortium 
Bipolar Disorder 
Working Group, 
2011) 
Major depressive disorder 37% (Sullivan, 
Neale, & 
Kendler, 2000) 
32% (Wray & 
Gottesman, 2012) 
8.9% (Major 
Depressive Disorder 
Working Group of the 
Psychiatric GWAS 
Consortium et al., 
2013) 
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Eating disorders 
Anorexia nervosa 57% (Dellava et 
al., 2011) 
64% (Strober et al., 
1990) 
~20% (Duncan et al., 
2017) 
Bulimia nervosa 62% (Bulik et al., 
2010) 
Not available Not available 
Binge-eating disorder 39% (Javaras et 
al., 2008) 
57% (Javaras et al., 
2008) 
Not available 
Purging disorder Not available† 
 
Not available Not available 
ARFID Not available Not available Not available 
Abbreviations: h2=narrow-sense heritability; ARFID=avoidant and restrictive food intake 
disorder 
†Munn-Chernoff et al. (2015) conducted a twin study of purging disorder and identified that 
44% of the variance attributable to familial factors, but were unable to distinguish between 
additive genetic and shared environmental factors. 
 
 
 
 
 
Figure legends 
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Figure 1. Standard ACE model of the classical twin design. Latent underlying factors: 
A=additive genetic factors, C=common/shared environmental factors, E=nonshared 
environmental factors and measurement error. Squares of paths: a2=heritability, which is in some 
depictions interchangeably with h2, c2=variance of common environmental factors, e2=nonshared 
environmental factors. 
 
Figure 2. Different degrees of genetic relatedness of family members. *Niece scientifically and 
linguistically correct named as first cousin once removed. 
 
Figure 3. Manhattan plot of genome-wide association study (GWAS) of body fat in UK Biobank. 
The x-axis displays all 22 autosomes and the y-axis the -log10 of the p-values of the association 
of every genetic marker (i.e., single nucleotide polymorphism, SNPs). The magenta line marks 
the genome-wide significance level of 5x10-8 and the blue area underneath indicates SNPs that 
did not reach genome-wide significance but may carry genetic information which can be 
summarized in polygenic risk scores (PRS). 
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Figure 4. Population structure within Europe. Displayed is the genetic data of 1,387 Europeans 
based on principal components (PC1 vs. PC2). The PC axes are rotated to emphasize the 
similarity to the geographic map of Europe. AL, Albania; AT, Austria; BA, Bosnia-Herzegovina; 
BE, Belgium; BG, Bulgaria; CH, Switzerland; CY, Cyprus; CZ, Czech Republic; DE, Germany; 
DK, Denmark; ES, Spain; FI, Finland; FR, France; GB, United Kingdom; GR, Greece; HR, 
Croatia; HU, Hungary; IE, Ireland; IT, Italy; KS, Kosovo; LV, Latvia; MK, Macedonia; NO, 
Norway; NL, Netherlands; PL, Poland; PT, Portugal; RO, Romania; RS, Serbia and Montenegro; 
RU, Russia, Sct, Scotland; SE, Sweden; SI, Slovenia; SK, Slovakia; TR, Turkey; UA, Ukraine; 
YG, Yugoslavia. Reprinted by permission from RightsLink: Springer Nature, Nature, Genes 
mirror geography within Europe, Novembre et. al. © (2008). 
 
 
Figure 5. Hypothetical relation between numbers of cases and genome-wide significant 
associations for a human complex disease or trait. After an initial dead zone with no genome-
wide significant associations an inflection point will be reached. At this inflection point the first 
genome-wide significant associations are detected and mostly their number increases linearly. 
The initial dead zone is dependent on the velocity of sample collection and effect sizes (adapted 
from Sullivan et al., 2018). 
 
